Detalhe da pesquisa
1.
Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges.
Curr Treat Options Oncol
; 24(6): 693-710, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099265
2.
Lack of efficacy of convalescent plasma in COVID-19 patients with concomitant hematological malignancies: An Italian retrospective study.
Hematol Oncol
; 40(5): 857-863, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932208
3.
Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational study.
Ann Hematol
; 101(4): 855-867, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35128571
4.
Overall survival of myelodysplastic syndrome patients after azacitidine discontinuation and applicability of the North American MDS Consortium scoring system in clinical practice.
Cancer
; 127(12): 2015-2024, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33739457
5.
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06.
Haematologica
; 106(10): 2578-2587, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855275
6.
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.
Haematologica
; 104(8): 1589-1596, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819917
7.
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.
Ann Hematol
; 98(10): 2329-2338, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31392461
8.
Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax.
Br J Haematol
; 203(4): e98-e101, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533098
9.
The use of erythropoiesis-stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib.
Br J Haematol
; 182(5): 701-704, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29984826
10.
Haplo-identical allografting with post-transplant cyclophosphamide in high-risk patients.
Ann Hematol
; 97(11): 2205-2215, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29987350
11.
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.
Ann Hematol
; 97(1): 95-100, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971265
12.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Am J Hematol
; 98(8): E204-E208, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222267
13.
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia.
Br J Haematol
; 191(1): e28-e32, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32686081
14.
Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients.
Haematologica
; 105(1): e13-e16, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31097634
15.
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation.
Ann Hematol
; 99(9): 2197-2199, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32661577
16.
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.
Haematologica
; 104(1): e4-e8, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076178
17.
Survival improvement of poor-prognosis AML/MDS patients by maintenance treatment with low-dose chemotherapy and differentiating agents.
Ann Hematol
; 93(8): 1391-400, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24705888
18.
Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party.
Blood
; 117(21): 5591-9, 2011 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21450900
19.
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
Hematol Oncol
; 31(2): 103-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22815278
20.
Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early treatment modifications in suboptimal responders: a retrospective study on 91 unselected patients.
Am J Hematol
; 88(10): 838-42, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23757199